EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications

Shiwei Yang iD, Xingming Hu, Jinmiao Zhu, Bin Zheng iD, Wenjie Bi, Xiaohong Wang, Jialing Wu, Zimeng Mi, Yifei Wu

Pharmaceutics · 08.05.2025 · 17 (5) · 623

DOI: 10.3390/pharmaceutics17050623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 08.05.2025. Verfasst von Shiwei Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Projects of Scientific Re-search Program of Higher Education Institutions in Anhui Province, Out-standing Youth Research Project for Universities in Anhui Province, Anhui Quality Engineering Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Quality by Design (QbD) has revolutionized pharmaceutical development by transitioning from reactive quality testing to proactive, science-driven methodologies. Rooted in ICH Q8–Q11 guidelines, QbD emphasizes defining Critical Quality Attributes (CQAs), establishing design spaces, and integrating risk management to enhance product robustness and regulatory flexibility. This review critically examines QbD’s theoretical frameworks, implementation workflows, and industrial applications, aiming to bridge academic research and commercial practices while addressing emerging challenges in biologics, advanced therapies, and personalized medicine.

Methods

The review synthesizes regulatory guidelines, case studies, and multidisciplinary tools, including Design of Experiments (DoE), Failure Mode Effects Analysis (FMEA), Process Analytical Technology (PAT), and multivariate modeling. It evaluates QbD workflows—from Quality Target Product Profile (QTPP) definition to control strategies—and explores advanced technologies like AI-driven predictive modeling, digital twins, and continuous manufacturing.

Results

QbD implementation reduces batch failures by 40%, optimizes dissolution profiles, and enhances process robustness through real-time monitoring (PAT) and adaptive control. However, technical barriers, such as nonlinear parameter interactions in complex systems, and regulatory disparities between agencies hinder broader adoption.

Conclusions

QbD significantly advances pharmaceutical quality and efficiency, yet requires harmonized regulatory standards, lifecycle validation protocols, and cultural shifts toward interdisciplinary collaboration. Emerging trends, including AI-integrated design space exploration and 3D-printed personalized medicines, promise to address scalability and patient-centric needs. By fostering innovation and compliance, QbD remains pivotal in achieving sustainable, patient-focused drug development.

Schlagwörter

Stichwörter der Autor:innen

design of experimentsdrug developmentquality by design

Autor:innen und Institutionen

  • Department of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Anhui Provincial Engineering Laboratory for the Development and Utilization of Medicinal and Edible Natural Resources, Hefei Normal University, Hefei 230061, China.

ORCID-Profile: Shiwei Yang, Bin Zheng

Förderung

  • Key Projects of Scientific Re-search Program of Higher Education Institutions in Anhui Province
  • Out-standing Youth Research Project for Universities in Anhui Province
  • Anhui Quality Engineering Program
  • Key Projects of Scientific Research Program of Higher Education Institutions in Anhui Province

Zitieren

APA

Yang, S., Hu, X., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., & Wu, Y. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics, 17(5), 623. https://doi.org/10.3390/pharmaceutics17050623

Vancouver

Yang S, Hu X, Zhu J, Zheng B, Bi W, Wang X, et al. Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics. 2025;17(5):623. doi:10.3390/pharmaceutics17050623

BibTeX
@article{Yang2025,
  author = {Yang, Shiwei and Hu, Xingming and Zhu, Jinmiao and Zheng, Bin and Bi, Wenjie and Wang, Xiaohong and Wu, Jialing and Mi, Zimeng and Wu, Yifei},
  title = {Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {623},
  doi = {10.3390/pharmaceutics17050623}
}
Kostenlos starten →